<SEC-DOCUMENT>0000049071-22-000060.txt : 20220915
<SEC-HEADER>0000049071-22-000060.hdr.sgml : 20220915
<ACCEPTANCE-DATETIME>20220915072258
ACCESSION NUMBER:		0000049071-22-000060
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220912
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220915
DATE AS OF CHANGE:		20220915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		221244479

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hum-20220912.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:542ceb5c-3cb3-4582-ba49-c837caaef56f,g:0dd29f17-aa2a-4fc5-b6be-9e26aa4c8f8d,d:d4e3aa1c918744988cbf7c966b478801--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hum-20220912</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV80L2ZyYWc6YWJkYTcyMzhlOGFhNGNhMmEzYWM0ZjdmMTdmMWFmYjgvdGFibGU6ZWE0NTg0YjQxMTA1NGJmOGI0NDE5YjVjZmVkNzlmNjAvdGFibGVyYW5nZTplYTQ1ODRiNDExMDU0YmY4YjQ0MTliNWNmZWQ3OWY2MF8yLTEtMS0xLTEzODU_553b26ba-8dca-422e-8576-78b3ab6a2841">0000049071</ix:nonNumeric><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV80L2ZyYWc6YWJkYTcyMzhlOGFhNGNhMmEzYWM0ZjdmMTdmMWFmYjgvdGFibGU6ZWE0NTg0YjQxMTA1NGJmOGI0NDE5YjVjZmVkNzlmNjAvdGFibGVyYW5nZTplYTQ1ODRiNDExMDU0YmY4YjQ0MTliNWNmZWQ3OWY2MF8zLTEtMS0xLTEzODU_44077ab1-c2af-45f3-b148-6cfc5b4c045c">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hum-20220912.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id4e3aa1c918744988cbf7c966b478801_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC&#160;20549</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.527%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc1_544a42e1-eda2-47be-95bf-fbc8409d561c">8-K</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.527%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): September 15, 2022&#160;(<ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8yNDM_d8fd9718-a683-419e-a11b-3a815c843b9b">September 12, 2022</ix:nonNumeric>)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.472%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjgw_b8191588-2209-47d9-a94b-b4d348d263b9">Humana Inc.</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.194%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.750%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6OTgxOTA4MmUxMmI3NDMzZjg2NWQyMDAwMmZiN2M0Y2IvdGFibGVyYW5nZTo5ODE5MDgyZTEyYjc0MzNmODY1ZDIwMDAyZmI3YzRjYl8wLTAtMS0xLTEzODU_bd9aa2db-a0b4-4fa8-b816-f02f906f72f9">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6OTgxOTA4MmUxMmI3NDMzZjg2NWQyMDAwMmZiN2M0Y2IvdGFibGVyYW5nZTo5ODE5MDgyZTEyYjc0MzNmODY1ZDIwMDAyZmI3YzRjYl8wLTEtMS0xLTEzODU_fd7ad2d9-0512-4268-81ce-f8abff4c7034">001-5975</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6OTgxOTA4MmUxMmI3NDMzZjg2NWQyMDAwMmZiN2M0Y2IvdGFibGVyYW5nZTo5ODE5MDgyZTEyYjc0MzNmODY1ZDIwMDAyZmI3YzRjYl8wLTItMS0xLTEzODU_fff3bc9b-5145-4f9c-aaa5-d8776cd8d03f">61-0647538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc3_ebd7e028-9c6b-4901-a297-bf3b428e8148">500 West Main Street</ix:nonNumeric>, <ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc4_40807ae2-02a0-45de-9148-e8350fa794eb">Louisville</ix:nonNumeric>, <ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc5_5320bfd8-c5bc-4dcf-9ab2-620b1b9e4579">Kentucky</ix:nonNumeric> <ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjcy_e2ddf632-a860-445f-8eb6-c213c5fd8b48">40202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjcz_343bf26e-04c4-40bd-89ed-5487c80cf5c8">502</ix:nonNumeric>) <ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjgx_c3dad3b4-9f4c-4494-beb3-5d3cfbf879a2">580-1000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.472%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6MGU4MmFmZTVhZTQxNDg4YjgwMjM0NTNhNjIyOWNkNmQvdGFibGVyYW5nZTowZTgyYWZlNWFlNDE0ODhiODAyMzQ1M2E2MjI5Y2Q2ZF8wLTAtMS0xLTEzODU_bb05ca88-5b46-4a45-a479-a8723e17b9a3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6NTU3NmMxNGFlMWRlNGZhY2JkNzZhNzNjOWU3YTI4MWYvdGFibGVyYW5nZTo1NTc2YzE0YWUxZGU0ZmFjYmQ3NmE3M2M5ZTdhMjgxZl8wLTAtMS0xLTEzODU_06de4d67-89a9-42c9-952e-6e67bef01a89">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6M2U4ZTA5ZWQwOTk1NGUxZWEyMjY2NDc4YTAwYzc4ZjEvdGFibGVyYW5nZTozZThlMDllZDA5OTU0ZTFlYTIyNjY0NzhhMDBjNzhmMV8wLTAtMS0xLTEzODU_bf24071d-066b-462b-a84c-512d6a5c4daa">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6YmM1MDJiNDE1ZWE3NGM4M2EwM2Y2Mjc1ZDg2MGM3ZDQvdGFibGVyYW5nZTpiYzUwMmI0MTVlYTc0YzgzYTAzZjYyNzVkODYwYzdkNF8wLTAtMS0xLTEzODU_39c98030-d84d-4b5c-82c0-18057f91041c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:36.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6ZDVhZmQ0YzVjZDJhNGE2ODhkNGM3ZGMwMzRkOTk4NmEvdGFibGVyYW5nZTpkNWFmZDRjNWNkMmE0YTY4OGQ0YzdkYzAzNGQ5OTg2YV8xLTAtMS0xLTEzODU_9051b8d1-bd17-4bc2-b50f-853475a2571c">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6ZDVhZmQ0YzVjZDJhNGE2ODhkNGM3ZGMwMzRkOTk4NmEvdGFibGVyYW5nZTpkNWFmZDRjNWNkMmE0YTY4OGQ0YzdkYzAzNGQ5OTg2YV8xLTEtMS0xLTEzODU_159cd904-2bbb-417b-8b0c-22983e241f2e">HUM</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6ZDVhZmQ0YzVjZDJhNGE2ODhkNGM3ZGMwMzRkOTk4NmEvdGFibGVyYW5nZTpkNWFmZDRjNWNkMmE0YTY4OGQ0YzdkYzAzNGQ5OTg2YV8xLTItMS0xLTEzODU_1afc2c1e-4fd2-49b3-ba97-8c85fe560c7f">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc0_98ea2052-714b-465a-a288-9df0a49841d9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="id4e3aa1c918744988cbf7c966b478801_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 5.02. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Departure of Directors or Certain Officers&#894; Election of Directors&#894; Appointment of Certain Officers&#894; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(d)        Effective September 15, 2022, the Board of Directors (the &#8220;Board&#8221;) of Humana Inc. (the &#8220;Company&#8221;) expanded its number of authorized directors from thirteen to fourteen and elected Brad D. Smith as a director of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Board of Directors has determined that (i) Mr. Smith is independent within the meaning of the New York Stock Exchange&#8217;s director independence standards; and (ii) there are no material transactions involving Mr. Smith and the Company. Under the agreement dated as of February 21, 2022 (the &#8220;Agreement&#8221;), between the Company and Starboard Value LP and certain of its affiliated entities and natural persons as set forth in the signature pages thereto (collectively, &#8220;Starboard&#8221;), the Company and Starboard have mutually agreed to Mr. Smith&#8217;s service.</span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">             </span><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Mr. Smith will be compensated in accordance with the Company&#8217;s standard compensation policies and practices for the Board, the components of which were disclosed by the Company in its current report on Form 8-K filed with the U.S. Securities and Exchange Commission on August 20, 2021. In connection with his election to the Board, Mr. Smith also will be granted restricted stock units (RSUs) in accordance with the Company&#8217;s director compensation program. Mr. Smith has not yet been appointed to any committees of the Board. </span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">             </span><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">On September 15, 2022, the Company issued a press release announcing the election of Mr. Smith, a copy of which is attached hereto as Exhibit 99.1, and is incorporated by reference herein.</span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">          </span></div><div id="id4e3aa1c918744988cbf7c966b478801_549755814019"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="-sec-extract:summary;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Item 7.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Regulation FD Disclosure.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Company issued a press release this morning announcing (i) as previously disclosed, the Company will be hosting a virtual Investor Day on Thursday, September 15, 2022, at 8:30 a.m., eastern time, that will be webcast through a link via the Company&#8217;s Investor Relations page at https://humana.gcs-web.com/; (ii) updated earnings expectations for the full year ending December 31, 2022; and (iii) the introduction of a mid-term earnings target for the full year ending December 31, 2025.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A copy of the press release is attached hereto as Exhibit 99.2, and is incorporated herein by reference.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="id4e3aa1c918744988cbf7c966b478801_549755814033"></div><div style="-sec-extract:summary;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Item 9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Financial Statements and Exhibits.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">        Exhibit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">s:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:13.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit991directorelection.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit991directorelection.htm">Press Release, Director Election</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit992investorday.htm">99.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit992investorday.htm">Press Release, Investor Day</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="id4e3aa1c918744988cbf7c966b478801_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.456%"><tr><td style="width:1.0%"></td><td style="width:13.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HUMANA INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">/s/ John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Senior Vice President, Chief Accounting Officer &amp; Controller</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated: September 15, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991directorelection.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icb7fcc0fe34a4f40bc7bb69e45623600_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="padding-left:72pt;text-align:right;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="padding-left:72pt;text-indent:-81pt"><img alt="image.jpg" src="image.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FOR MORE INFORMATION, CONTACT  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                          </font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lisa Stoner</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investor Relations</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Humana Inc.</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">502-580-2652</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">lstamper&#64;humana.com</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">or</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mark Taylor</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Corporate Communications</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Humana Inc.</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">317-753-0345</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">mtaylor108&#64;humana.com</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:112%">Humana Elects Brad D. Smith to Board of Directors</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">LOUISVILLE, Ky.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> &#8212; September 15, 2022 &#8212; Humana Inc. (NYSE&#58; HUM) announced today that Brad D. Smith, former Executive Chairman, President and CEO of Intuit Inc., has been elected as a member of the Company&#8217;s Board of Directors. He currently serves as the President of Marshall University, having assumed the role of leading his Alma Mater in January 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Prior to joining Marshall, Smith was Executive Chairman of Intuit from January 2019 until January 2022, following 11 years as Intuit&#8217;s President and CEO from January 2008 to December 2018.  During Smith&#8217;s tenure, he led Intuit&#8217;s transformation from a North American financial software company into a global cloud-based platform company, leading to historic record growth that nearly doubled the company&#8217;s revenue and positioned Intuit as a leading company in its industry.  Smith continues to serve on the Intuit Board of Directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;We are pleased to welcome Brad to the Humana Board.  He is a seasoned CEO with proven experience in driving transformation through data-driven decision making, rapid experimentation, and customer focus,&#8221; said Humana Chairman of the Board Kurt J. Hilzinger. &#8220;Brad&#8217;s deep operating experience and ability to innovate across all organizational layers, while also being mission and customer driven, will be vital as Humana continues to grow its core Medicare Advantage business, drive operational efficiencies, and mature and further integrate its healthcare services offerings.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">His election brings the number of Humana directors to 14.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">About Humana </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Humana Inc. (NYSE&#58; HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools &#8211; such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions &#8211; combine to produce a simplified experience that makes health care easier to navigate and more effective.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">More information regarding Humana is available to investors via the Investor Relations page of the company&#8217;s website at humana.com, including copies of&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:14.15pt">Annual reports to stockholders</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:14.15pt">Securities and Exchange Commission filings</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:14.15pt">Most recent investor conference presentations</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:14.15pt">Quarterly earnings news releases and conference calls</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:14.15pt">Calendar of events</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Corporate Governance information</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"># # #</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit992investorday.htm
<DESCRIPTION>EX-99.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icc2c60741813499baf56db5f1ec99788_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="padding-left:72pt;text-align:right;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 99.2</font></div><div style="padding-left:72pt;text-indent:229.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.576%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:95%">Humana Inc.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">500 West Main Street</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">P.O. Box 1438</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Louisville, KY  40201-1438</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">http&#58;&#47;&#47;www.humana.com</font></div></td></tr></table></div><div style="padding-left:31.5pt;text-indent:297pt"><img alt="imagea.jpg" src="imagea.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:95%">FOR MORE INFORMATION CONTACT  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:95%">                                    </font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lisa Stoner</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Humana Investor Relations</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(502) 580-2652</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e-mail&#58; LStamper&#64;humana.com</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mark Taylor</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Humana Corporate Communications</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(317) 753-0345</font></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e-mail&#58; MTaylor108&#64;humana.com</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:15.5pt;font-weight:700;line-height:112%">Humana Introduces Mid-Term Adjusted EPS Target of $37 in 2025 and Raises Full Year 2022 Adjusted EPS Financial Guidance to &#8216;approximately $25&#8217; at Investor Day</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Introduces a mid-term Adjusted EPS target of $37.00 per diluted common share for the year ending December 31, 2025, representing a compelling 14 percent compounded annual growth rate over the company&#8217;s updated FY 2022 Adjusted EPS outlook</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Expects to deliver continued earnings growth in 2026 and beyond at or above the EPS growth trends reflected in its new mid-term Adjusted EPS target</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Raises FY 2022 GAAP EPS guidance to &#8216;approximately $23.08&#8217; from its previous estimate of &#8216;approximately $20.30&#8217;, while also increasing FY 2022 Adjusted EPS guidance to &#8216;approximately $25.00&#8217; from the previous guidance of &#8216;approximately $24.75&#8217;, reflecting 21 percent growth over 2021</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Louisville, KY &#8211;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> September 15, 2022 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211; As previously disclosed, Humana Inc. (NYSE&#58; HUM) will host a virtual Investor Day today, Thursday, September 15, 2022, at 8&#58;30 a.m. eastern time.  The Investor Day will include presentations by senior management focusing on Humana&#8217;s value creation framework as the company continues to gain operational momentum and advance its strategy for sustainable leadership in the value-based care industry. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Adjusted EPS Target for FY 2025</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As part of today&#8217;s virtual Investor Day, the company is introducing a mid-term Adjusted EPS target of $37.00 per diluted common share for the year ending December 31, 2025 (FY 2025), representing a compelling 14 percent compounded annual growth rate over the company&#8217;s updated FY 2022 Adjusted EPS outlook.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company expects to grow enterprise earnings approximately 10 percent per year, before factoring in an additional 1 to 2 percent of anticipated earnings growth driven by the company&#8217;s commitment to improving operating leverage by approximately 20 basis points annually, on a business mix adjusted basis.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, Humana expects capital deployment to contribute approximately 2 percent to annual EPS growth. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We are confident in our ability to deliver compelling, sustainable earnings growth, both in the near and longer term which will continue to drive shareholder value. Our strong competitive positioning and unique capabilities in the highly attractive individual Medicare Advantage market, coupled with the opportunity to scale and further integrate our CenterWell healthcare services capabilities, positions us for durable leadership in the value-based care industry,&#8221; said Bruce D. Broussard, Humana&#8217;s President and Chief Executive Officer.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Additionally, our sharpened focus on driving ongoing operating efficiencies enabled by our $1 billion value creation initiative and efficient capital deployment drive visibility into the medium- and longer-term outlook. We expect to deliver $37.00 Adjusted EPS in 2025 and continued earnings growth in 2026 and beyond at or above the EPS growth trends reflected in our new mid-term target.&#8221; </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">FY 2022 GAAP and Adjusted EPS Guidance</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana today increased its GAAP and Adjusted EPS guidance for the year ending December 31, 2022 (FY 2022).</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FY 2022 GAAP EPS guidance was increased to &#8216;approximately $23.08&#8217; from its previous estimate of &#8216;approximately $20.30&#8217;, while Adjusted EPS was increased to &#8216;approximately $25.00&#8217; from the previous guidance of &#8216;approximately $24.75&#8217;. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The updated Adjusted guidance reflects 21 percent growth compared to FY 2021 Adjusted EPS results and is driven by the continued lower-than-expected medical cost trends in the company&#8217;s Medicare Advantage and Medicaid businesses and the lack of a COVID-19 headwind materializing to date.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Importantly, the company no longer deems it necessary to hold a discrete COVID-19 headwind in its full year guide.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a result, it has now released the remaining $0.50 explicit COVID-19 headwind embedded in its previous FY 2022 Adjusted EPS guidance.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company is raising its FY 2022 Adjusted EPS guide by $0.25 to &#8216;approximately $25.00&#8217; today, with the assumption that it will invest the remaining $0.25 in additional marketing for the 2023 Medicare Advantage Annual Election Period if the dollars are not needed to cover items such as a higher-than-expected flu season, should it emerge.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Detailed components of the company&#8217;s FY2022 financial guidance updated today will be provided in the company&#8217;s third quarter 2022 earnings release on November 2, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A reconciliation of GAAP to Adjusted EPS for the company&#8217;s FY 2022 projections as well as comparable numbers for the year ended December 31, 2021 (FY 2021) is shown below&#58;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.729%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Diluted Earnings Per Common Share</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FY 2022 Guidance</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(a)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">FY 2021 (b)</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Generally Accepted Accounting Principles (GAAP)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%">approximately $23.08</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">$22.67</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Amortization of identifiable intangibles</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">0.43</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">0.39</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Gain on Kindred at Home equity method investment</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">-</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(8.73)</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Put&#47;call valuation adjustments associated with company's non- consolidating minority interest investments</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(0.18)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.56</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Transaction and integration costs</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">0.61</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">0.72</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Change in fair market value of publicly traded equity securities</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">1.03</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.03</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Charges associated with productivity initiatives related to the previously disclosed $1 billion value creation plan</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">1.45</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">-</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Estimated net gain on the sale of Kindred at Home&#8217;s Hospice and Personal Care divisions</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(1.42)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">-</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Adjusted (non-GAAP) &#8211; FY 2022 projected&#59; FY 2021 reported</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%">approximately $25.00</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">$20.64</font></div></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Investor Day Logistics</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Presentations will begin at 8&#58;30 a.m. Eastern.</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Investor Day webcast and virtual presentation may be accessed via Humana&#8217;s Investor Relations page at https&#58;&#47;&#47;humana.gcs-web.com&#47;. The company suggests web participants sign on approximately 15 minutes in advance of the event. The company also suggests web participants visit the site in advance to run a system test and to download any free software needed.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For those unable to participate in the live event, the replay will be available in the Historical Webcasts and Presentations section of the Investor Relations page at humana.com approximately 4 hours following the live webcast.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Footnotes</font><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The company has included financial measures throughout this press release that are not in accordance with GAAP.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management believes that these measures, when presented in conjunction with the comparable GAAP measures, are useful to both management and its investors in analyzing the company&#8217;s ongoing business and operating performance.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consequently, management uses these non-GAAP financial measures as indicators of the company&#8217;s business performance, as well as for operational planning and decision-making purposes.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. All financial measures in this press release are in accordance with GAAP unless otherwise indicated.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)   </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">FY 2022 projected Adjusted results exclude the following&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Amortization expense for identifiable intangibles of approximately $0.43 per diluted common share. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Put&#47;call valuation adjustments of approximately $0.18 per diluted common share, associated with Humana&#8217;s non-consolidating minority interest investments as of June 30, 2022. FY 2022 GAAP EPS guidance excludes the impact of future value changes of these put&#47;call options as the future value changes cannot be estimated.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Transaction and integration costs of approximately $0.61 per diluted common share.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Change in fair market value of publicly traded equity securities of $1.03 per diluted common share as of June 30, 2022. The future value of publicly traded equity securities, their impact on GAAP EPS, and the related non-GAAP adjustment will fluctuate on the public trading value of the stock. The guidance set forth herein assumes no further change in the fair value of these investments.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Estimated charges of $1.45 per diluted common share, primarily associated with initiatives undertaken related to the company's previously disclosed $1 billion value creation plan to create capacity to fund growth and investment in its Medicare Advantage business and further expansion of its Healthcare Services capabilities in 2023. FY 2022 GAAP EPS guidance excludes the future impact of potential charges related to the value creation plan.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Estimated net gain of $1.42 per diluted common share related to the sale of Kindred at Home's Hospice and Personal Care divisions in August 2022.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)   </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">FY 2021 Adjusted results exclude the following&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Amortization expense for identifiable intangibles of approximately $0.39 per diluted common share. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Gain associated with Kindred at Home equity method investment of approximately $8.73 per diluted common share&#59; the gain was recorded upon closing of the Kindred at Home transaction in August 2021. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Put&#47;call valuation adjustments of approximately $3.56 per diluted common share, associated with Humana&#8217;s non-consolidating minority interest investments, including the impact of the termination of the put&#47;call agreement related to Kindred at Home as a result of the transaction announced on April 27, 2021.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Transaction and integration costs of approximately $0.72 per diluted common share.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Change in fair market value of publicly traded equity securities of $2.03 per diluted common share.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement</font><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of Humana&#8217;s executive officers, the words or phrases like &#8220;expects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;likely will result,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221; or variations of such words and similar expressions are intended to identify such forward-looking statements. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the &#8220;Risk Factors&#8221; section of the company&#8217;s SEC filings, a summary of which includes but is not limited to the following&#58; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana&#8217;s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana's reserves may be insufficient. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; If Humana fails to effectively implement its operational and strategic initiatives, particularly its Medicare initiatives and state-based contract strategy, the company&#8217;s business may be materially adversely affected, which is of particular importance given the concentration of the company&#8217;s revenues in these products. In addition, there can be no assurances that the company will be successful in maintaining or improving its Star ratings in future years. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; If Humana fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems, to protect Humana&#8217;s proprietary rights to its systems, or to defend against cyber-security attacks or prevent other privacy or data security incidents that result in security breaches that disrupt the company's operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company&#8217;s business may be materially adversely affected. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company&#8217;s cost of doing business. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts&#59; governmental audits and investigations&#59; potential inadequacy of government determined payment rates&#59; potential restrictions on profitability&#59; including by comparison of profitability of the company&#8217;s Medicare Advantage business to non-Medicare Advantage business&#59; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage, or MA, plans according to the health status of covered members, including proposed changes to the methodology used by CMS for risk adjustment data validation audits that fail to address adequately the statutory requirement of actuarial equivalence, if implemented, could have a material adverse effect on the company's operating results, financial position and cash flows.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> &#8226; Humana's business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humana&#8217;s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company&#8217;s ability to expand into new markets, increasing the company&#8217;s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company&#8217;s Medicare payment rates and increasing the company&#8217;s expenses associated with a non-deductible health insurance industry fee and other assessments)&#59; the company&#8217;s financial position (including the company&#8217;s ability to maintain the value of its goodwill)&#59; and the company&#8217;s cash flows. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> &#8226; Humana&#8217;s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company&#8217;s results of operations, financial position, and cash flows.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company&#8217;s business may be adversely affected. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the Company&#8217;s success, and its failure to do so could adversely affect the Company&#8217;s businesses, operating results and&#47;or future performance. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Humana&#8217;s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Changes in the prescription drug industry pricing benchmarks may adversely affect Humana&#8217;s financial performance. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Humana&#8217;s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Downgrades in Humana&#8217;s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; The securities and credit markets may experience volatility and disruption, which may adversely affect Humana&#8217;s business. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; The spread of, and response to, the novel coronavirus, or COVID-19, underscores certain risks Humana faces, including those discussed above, and the ongoing, heightened uncertainty created by the pandemic precludes any prediction as to the ultimate adverse impact to Humana of COVID-19. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As the COVID-19 pandemic continues, the premiums the company charges may prove to be insufficient to cover the cost of health care services delivered to its members, each of which could be impacted by many factors, including the impacts that Humana has experienced, and may continue to experience, to its revenues due to limitations on its ability to implement clinical initiatives to manage health care costs and chronic conditions of its members, and appropriately document their risk profiles, as a result of the company&#8217;s members being unable or unwilling to see their providers due to actions taken to mitigate the spread of COVID-19&#59; increased costs that may result from higher utilization rates of medical facilities and services and other increases in associated hospital and pharmaceutical costs&#59; and shifts in the company&#8217;s premium and medical claims cost trends to reflect the demographic impact of higher mortality during the COVID-19 pandemic. In addition, Humana is offering, and has been mandated by legislative and regulatory action (including the Families First Act and CARES Act) to provide, certain expanded benefit coverage to its members, such as waiving, or reimbursing, certain costs for COVID-19 testing, vaccinations and treatment. These measures taken by Humana, or governmental action, to respond to the ongoing impact of COVID-19 (including further expansion or modification of the services delivered to its members, the adoption or modification of regulatory requirements associated with those services and the costs and challenges associated with ensuring timely compliance with such requirements), and the potential for widespread testing, treatments and the distribution and administration of COVID-19 vaccines, could adversely impact the company&#8217;s profitability. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The spread and impact of COVID-19 and additional variants, or actions taken to mitigate this spread, could have material and adverse effects on Humana&#8217;s ability to operate effectively, including as a result of the complete or partial closure of facilities or labor shortages. Disruptions in public and private infrastructure, including communications, availability of in-person sales and marketing channels, financial services and supply chains, could materially and adversely disrupt the company&#8217;s normal business operations. A significant subset of the company's and the company's third party providers' employee population are in a remote work environment in an effort to mitigate the spread of COVID-19, which may exacerbate certain risks to Humana&#8217;s business, including an increased demand for information technology resources, increased risk of phishing and other cybersecurity attacks, and increased risk of unauthorized dissemination of sensitive personal, proprietary, or confidential information. The continued COVID-19 pandemic has severely impacted global economic activity, including the businesses of some of Humana&#8217;s commercial customers, and caused significant volatility and negative pressure in the financial markets. In addition to disrupting Humana&#8217;s operations, these developments may adversely affect the timing of commercial customer premium collections and corresponding claim payments, the value of the company&#8217;s investment portfolio, or future liquidity needs. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The ongoing, heightened uncertainty created by the pandemic precludes any prediction as to the ultimate adverse impact to Humana of COVID-19. Humana is continuing to monitor the spread of COVID-19, changes to the company&#8217;s benefit coverages, and the ongoing costs and business impacts of dealing with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:112%">n e w s</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:400;line-height:112%">r e l e a s e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">COVID-19, including the potential costs and impacts associated with lifting or reimposing restrictions on movement and economic activity, the timing and degree in resumption of demand for deferred healthcare services, the pace of administration of COVID-19 vaccines and the effectiveness of those vaccines, and related risks. The magnitude and duration of the pandemic remain uncertain, and its impact on Humana&#8217;s business, results of operations, financial position, and cash flows could be material. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance&#58; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Form 10-K for the year ended December 31, 2021&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022&#59; and </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; Form 8-Ks filed during 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#1d5b2d;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">About Humana</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Humana Inc., headquartered in Louisville, Ky., is a leading health and well-being company focused on making it easy for people to achieve their best health with clinical excellence through coordinated care. The company&#8217;s strategy integrates care delivery, the member experience, and clinical and consumer insights to encourage engagement, behavior change, proactive clinical outreach and wellness for the millions of people we serve across the country.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">More information regarding Humana is available to investors via the Investor Relations page of the company&#8217;s web site at </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">www.humana.com,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> including copies of&#58; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">Annual reports to stockholders </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">Securities and Exchange Commission filings </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">Most recent investor conference presentations </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">Quarterly earnings news releases and conference calls</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">Calendar of events</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">Corporate Governance information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hum-20220912.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:542ceb5c-3cb3-4582-ba49-c837caaef56f,g:0dd29f17-aa2a-4fc5-b6be-9e26aa4c8f8d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hum="http://www.humana.com/20220912" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.humana.com/20220912">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20220912_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20220912_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.humana.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hum-20220912_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:542ceb5c-3cb3-4582-ba49-c837caaef56f,g:0dd29f17-aa2a-4fc5-b6be-9e26aa4c8f8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_71b1a6d2-559f-4e2d-a20e-57d05b835488_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3e3909e0-f16a-470e-831b-bbd53fb7aaf6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ad1a8e23-6cc5-4def-8972-2aff6032f638_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ed653a91-367b-408f-8c3b-be0c602c7016_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_98164fcb-e3bc-4aed-b4af-5b507d334519_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_83de809f-c7d9-421e-8136-d44c14edefed_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_eeccde92-8606-4259-9507-efe1d8a71932_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f72e3331-4398-40f4-a49b-98a1d119c3b5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5cc05421-1350-4726-9ae9-755bdfbe8182_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6b68024f-f126-42d2-8c90-249fdd43158b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ce07af62-9ce6-4450-9f32-7280eebca823_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_03190957-bb31-4d67-b716-20f49719703c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5ee73cb4-8403-4996-98c0-6c32692459d2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6c5dbf72-db56-48ce-9ac9-1f660ba26117_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fd29320b-6830-4b5e-816b-0f440db1c97a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a9e5e7a6-8d35-45d1-bc1c-93543d36b1a1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a44301de-c44f-4304-bd91-a1f2d777a044_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e3f650f1-0330-4de0-a73c-17024bcb1379_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a0534cda-9d23-4e05-a6cc-57492e617aa6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_58fe8191-5092-41e6-9582-f5b4f47db497_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d20a4872-e210-44c8-95c3-998fe33befac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c527ecc0-d7af-48a9-9293-26958d29fc6f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6d6754ac-8edb-491b-bb38-cea6fc092432_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hum-20220912_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:542ceb5c-3cb3-4582-ba49-c837caaef56f,g:0dd29f17-aa2a-4fc5-b6be-9e26aa4c8f8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/Cover" xlink:type="simple" xlink:href="hum-20220912.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bcd21baf-d20e-43bb-aaa2-8f3415064ec4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_DocumentType_bcd21baf-d20e-43bb-aaa2-8f3415064ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1c939e72-bec3-49bc-bcb7-e851fe53e144" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_DocumentPeriodEndDate_1c939e72-bec3-49bc-bcb7-e851fe53e144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cc2700b0-9229-4d8b-aa6c-24f7a91def9f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityRegistrantName_cc2700b0-9229-4d8b-aa6c-24f7a91def9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7634e1a7-bd7f-4178-b4fc-6241c76bc035" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7634e1a7-bd7f-4178-b4fc-6241c76bc035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8cd9c506-a393-4f91-955a-26aae4020e78" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityFileNumber_8cd9c506-a393-4f91-955a-26aae4020e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c40df17d-63f6-418b-8435-6e725ffb23b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityTaxIdentificationNumber_c40df17d-63f6-418b-8435-6e725ffb23b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1294cf2a-b82b-4b0a-a2b7-b5401703cda9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityAddressAddressLine1_1294cf2a-b82b-4b0a-a2b7-b5401703cda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_97d6e6b4-3e98-430a-972e-a34686193c07" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityAddressCityOrTown_97d6e6b4-3e98-430a-972e-a34686193c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_06fdfd01-4727-43a1-9404-646a11699253" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityAddressStateOrProvince_06fdfd01-4727-43a1-9404-646a11699253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f46a25ce-3572-4a43-ba18-e3586012270f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityAddressPostalZipCode_f46a25ce-3572-4a43-ba18-e3586012270f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_40522bc3-012d-4777-ba0f-d9733f1a4572" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_CityAreaCode_40522bc3-012d-4777-ba0f-d9733f1a4572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0b8de4fd-c274-4851-9b9d-f90f2eb3cea3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_LocalPhoneNumber_0b8de4fd-c274-4851-9b9d-f90f2eb3cea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_7f34549b-861f-4024-b222-e37fda4fcea1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_WrittenCommunications_7f34549b-861f-4024-b222-e37fda4fcea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e88f26cd-3ade-4b3a-b925-1c1fba3d1205" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_SolicitingMaterial_e88f26cd-3ade-4b3a-b925-1c1fba3d1205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_587d5a08-0847-4325-ac4e-aba2487da1b4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_PreCommencementTenderOffer_587d5a08-0847-4325-ac4e-aba2487da1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_7afeb6c7-0931-4138-b5d6-4a48c0202ae9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_7afeb6c7-0931-4138-b5d6-4a48c0202ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f4887555-e94b-4b32-8f1f-745c297efc42" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_Security12bTitle_f4887555-e94b-4b32-8f1f-745c297efc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_bd3398e1-03a8-4e76-af0f-a8705553a149" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_TradingSymbol_bd3398e1-03a8-4e76-af0f-a8705553a149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5aa7c10e-2563-439f-9356-0adea08ee7ee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_SecurityExchangeName_5aa7c10e-2563-439f-9356-0adea08ee7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_99b32bcb-d0e4-463f-bd68-dd44ead4b7ee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityEmergingGrowthCompany_99b32bcb-d0e4-463f-bd68-dd44ead4b7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ccc7be84-4fdc-435e-b048-c99c6d3fb3d4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_EntityCentralIndexKey_ccc7be84-4fdc-435e-b048-c99c6d3fb3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a3460974-36a7-45f9-b3c1-b388f6215fc2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2098f4c-1753-4120-8688-28411a8288b7" xlink:to="loc_dei_AmendmentFlag_a3460974-36a7-45f9-b3c1-b388f6215fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image.jpg
<DESCRIPTION>HUM LOGO
<TEXT>
begin 644 image.jpg
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MN&J?/%?SOWN'_%B>NXWX*1T\MD>>IZXK85_5PME\G=$VI4UBX?'[TI06\ES
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M,23'X!B20W#,R"$X9N00'#-R"(X9.03'C!Q")#-6[9DG2_M >X]NTZ[QP')
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M$ (G& X.(7""X> 0 B<8#@XA<(+AX! ")Q@.#B'(2#"&+O\KC5[YOH_&KOQ
MOTT/XU;UEBV;=EPCOWA'OW5PJ!]D)!BW]3U7-M;;A$/-#NO]PZGB0.4N.208
MAQ[8<>%D<@>'^D1&@M&TWWF^TQQ .#P+F_+3 2YWP5$X<A2,'9<3#(=Z1M8$
MHZ#D,CF:)AT<K-Q-<N=$X-@4)Q@.]8VL=:4R%PQ8#/\1G4XP'.H;.6(QZK(K
M%7^6432,WV"8=.*PD6FX**0:7S;2C8HC6V4R\=B_=MS92B<U9&@QSO%I>%#M
M6XRPBDFWLFJK<A/%6YL,31!W[ "XFJ;/X4,.D_-0T_AS$PUFC('3 RM/'H[=
MWJIN<#5WQ25G#DX]K)0;9+WPU=6G]-O$V'S@"YJS<:A,4W\PIPM]./=^*ESX
M.(U;W9M6[)ZM?85CY^'U-&5-7^J[X%&Y.770DE=I]L8A5'[4G&*8.5"&Q;A=
M=OG?Z./Y#]!'<WO(K;33UI70TAU3:?>13=IG9@ _5^V92Y^N'R!E?Q]EGW,_
M_7W. S1B12^YV18G+68#Z_8OIBE?]J/!2U^G]V=WH>%?O,5E^:M<AKFA?*D<
M7UJ7:#""L7'_4FK6[WPY%!A6!H3G=S_MK'U$ XVF13$NEU3A0+<7-:)5N^=H
M'Q M")<2L EK^]##HWXEERTVYS21'SM_-K7I?SFUX+C:EC2AR5\62?A-!U;0
MPZ-_+<?F(PZY9#(03@ZH+FQ$?1<])F$2:V6&O%9^<*<?;F=J57B1G-&+,V"#
M\;?A.L5=(S@_%^?#XN:F=V;=+8W9Q..AFO8?V\&-\C5Z:.1-,O6>5W0!UU-C
M*L"IZH&X#>'N/O  >1G. FGB\O^&01WKN73'-.HTZ-^X'BZ@UMQ^T%N(2Z.,
M>Q#\KB77,0Z%QKV%3T_X'QJSZGU6#(F.>*T9,A2,<^,*4-N"L:E\>7SE\3/N
M9TB&MV=V\L4/*N &C0.!@\#5 [$#AO&K;QP-AH\C]H-&"J%3]SYP&)SBS;]M
MR_SE\\)P%Y*%!I?@G#IS0N<@&NOW?DZWRU7"R!_B1<-1:83'K[JFRC_^OHJ:
M]3U/Q^9ON$W9'8=#2WZ94KD66>*64]<YC)0#]V>$W_@:1-?AUPD_<8>?RINJ
MK[!TV@L_^%G\('^<-J<W=/GK.K;L(WL6@R6YXC@.$D:%)](6'M(9?!O!L/V"
M,:]-3RX8;WW:T1<_J( 9$B88=PWZ7IQ?(6$(&CB8HQJF8I9^COGS?N$?=W9[
M_C53?6&NEM^6K-WCX=7CLIW3XTY";\_QF"/W(7S2F'4Z8D4X;?D=8,+@0LSP
MBUE:RAWI7MPJ?IU'I&/G.Y:.\:O],=W>]ZLZ1KL-\+/\J=SB++!<A\QU(W6K
MA5+B1WTQ<1G5-0E>.G@>P=VMVD+6!M^XY6<J]Q$5[$J)1CJ#;]MBV)2J8 3#
MX8CZ<,'X;IQ?(6YD^9Q7W&&-^\);,<&RH/&$^F>"-H5&A_#+W==,;4K,#:S^
M,J,.HB[3/WWF%&MZ6 K/OX1A0OKJ'F]U[P2Z=5A-$&>U-$4*!H='@[/]JO2:
M<%SH6JD[R-4=WA=+V=N5<5E01A$<'88;]W,A%_4;/#[V=RI?$DZ'@?+@^D"W
MK64AZACWD3>2/*$;B%N@Q'H'RI)S@A%F,9!IW"V'S)[D@=+)TY7Z]W@D[3VR
MI49=*3S7A<6 $$U?5\K]<._X_HH3Y31PZ:O2(.T\V03F#EKR,E587<R%6\9(
MPY7&$?"/AA"&%R??SFF@<?C#H,&^,C5?!O@V< ?>QOW+1%DIK>^%2\=BX)*:
MR6O[T<;R9;[C_L_P\VRYU8GCAU^[+!Q'"QZ7G6%A]J.:]AW;QF6\6.7)%T99
MNT5;QO+HPU.JF'#9>W0K]9G?DP71?X-4PQ$,3<BPN1P_&>%BE[ X<DTP8-6B
ML'D_\A4_.$?Y<+]#/*JIZM0QU1!C_KE,W.C15:H\$3^@Q 1 S"^$@\N-J\8F
MK^VK?81#C95,&HK2$8S6Q?$7[P1A+$V,. Y,2&!6+ A8$MNO3$IP63HFN><1
M=VI@_&:';7""D0UJ.(*AM%L+-O_!,!",W168+@WO5@;OU$99H(&W'UJK?2B@
MW+Z9(92?&]\=_*L0W6VM7<%0Z98M?L''$\D?EZ/WW&[RWD9!4(&PWWQ.0ZVQ
MB[Z ID$+!@9G<0/1*&(__@&HGQ()AAVF_@5#H?N(_X@+ \'8(X(1CI>GY,6%
MP11K4# &<7?-5T\RF+^"BC][1ON(AAH#>?&#LFLQJFG#_B5^P=#T_.3;M!\%
M=,5D1LWXD?:B;H)-AC#! .6<8(0-OE%0F2'!W_R;B-0LAQJ$!N,!Y=K@&^.(
M1'AF_)_BPF#LE$PP@F$*0BS&Z]/:^OR@SC UOGS'=.TC&L9BV.'3&7RG(AB[
M*S:+UK?#@9X<_T?M1T'N560%8]XK8;^2N@S]B?81#0@&ZL:.']0@+ 9F#OHM
M>)1*%S]/_3]_+B'U7?"XS#:T[Z^F*H/4D,88P%,3_A07)EL6XXWI[:1QQ_SQ
M<^O22T53)T-=C#'V'-DB^;'#@9Z:\-_:A\*>(YMD]BSF!VDQ_Y[FNDN&!M25
M"O_ %W8A8B+<.>#;4CG2K;+BJAO!"/_ EWN"H2R&\8-GU'5."4;(Y$.\8&P6
M*VK[05F>'N_W%X8&/<9(Y\NW&2ZNWCV7*Y7-,+I75ES.8GAP@G$6"8;!H:H]
MJK+JQ6(T4,'@?OD_BF!@ZOFI<?ZQ2!@:C&#4Q[+S7!Y\0S""8;(U^#:"81/J
M(1W!L,-F=_"M! /?H^QPH*<"EL (ANT'>4O58C38P7?F@I&JQ5@6:C%>G]Y&
M^XA&0[88KT]K$R@SZOI26K%SIO81C5RR&/N.;F7ALRW&U<+W;L.OUSZBT8 L
M1MUO;=TH%@,,\/QACO[AT3=I']$(MQA1@^_<LA@#E[XB70[C1WTEOX+Z+WY1
M^XA&3#"L-.K%8O"@\DSU*6K>[X+8>Y4O+%OWOF.HI?_Q<!9#4YA@'#]UC/*+
M+U$5JOV9"DZ&AFHQT$S6[EG #=S2EB(D5U&'LF\H3PF02Q8#0'P^?UQ>[%<Y
M>O*P]A&.LV[PG8Y@ "U8XZ@/0\H?EEH7E%PAN]@\&*WC:9]>G][EBQ_44+I2
ML2_&W&A%$<3\7D%S-XW0OH!X;5M0@H5WJLMBPM6/8*B\/3#J%XI_2,<JR[U#
M?BSOX2^>>T1%BQZ77H6418>)%PR$4*&.GCA$1X\?D.=,T6"Z4L"#HW[)E>)/
M%Q\)\>7UM6EM:?V^Q5(IQT]7T2YNE*MVSZ4Q*]^C>X9>ZPL#:BA=*:#'R)]Q
MN>.[$OA@UGMN=ZJR%AZB_*-6O$/8':CV.:!N54,"U=?@&UBS9QZWDTOEO1%T
M0YVXWM<')A36L+6\;]BUREK(B@E_F*!@8+55AP'?I(5;Q]!25I;PD^F6V 9C
M,:!+=AQ>+U_,46"C>61S"\+QWP6EV *)M?P7BL;&HKS@QT-##<-B* V(Y=I8
MTJ\TNBZO17G%V".ARMVR^")6%MQPN"&UD?&(KBOMMSZ[4L =8L&P"<KVC_PI
M_F$K+NJ[>>'Y5,#M0'B-[B-V0<J^#45^P5#UU)EY!_QEP+=%T" J$)1,T( L
MABH\MK)ZYMBO0=*AAF0Q .SSQJ [&"9(4B=H1#$MB[KUZK<^+0:  QRPRP\\
M#(:Q*;:/A']5EQ#\]K>3H&#<-5 M7[][R _IX3&_ILH3%?3 R)^+6[IH4&,,
MTP/]Z\P[E :UPJ1#L#(M6:.O##GA(]?&&#8^GO^0JJ] .)L@!%A-\-JT-G1'
MV3=ESX-L)M)4WQ8#P,:JVPNME;8A9/:R8T?BF)4?L/7'RFKKO4\P%+!>#RCY
M[&FZ9\@/Y+G#@.23%&'(2##^]/'_E1DBFYKQ /'HB8/:1VK 3K.F?<Z1[I$=
M5_.B<.;9V']T!_7$21S<EY;MCRR8F(61/=9,:"#8S-.:&Q(T/C0BF/_8V%MH
MZ/(WZ1 +I1]*Z-"83#YPKFY^T<5T6Y]SY5T4GIUXJ^1!3NY@PDQ+LS[GT;XC
MV[2/(*I%N.TR@["[;=O!-=I/./8=W4Y=AU\OVS_5<AI8!]:@;$VP+12-9X4^
M_03**EBWMWWR%7EGRFO0E,MH^P/A%))DP X[6 #QS\K*A'UTW,W:1S0^G-U5
M^)=?I+J]QD*@7,W[-:*^"Q\1?S/6ERD^LS\3/^HX>!C"UD.KZ9$QO]5_$3W-
MPHFC=S)!1H*!)<38G6:3=Y2)O\*3H9('B^7'=OCB*F=*#'\:AZKVTF=;Q\N1
M*J-7ODNC>, ];F5O6K!Y#&TYL)*]Q^<I*I<'*[V\(!_XK6+S'WZ\#=R4>_E1
M._^[Z,A)/2L2%PYV3VW*V7]T6RR,H=-G3LJ[:'CQ;=BWE"9_V8\'V^_1K(U#
MZ/AI?<83>ZG6Z>[CND5^3/Q(,Y@C #PHK_3R@;^30J=QY,0!'<8+KWH/82G%
MX_#Q?31O\W IQYA5']"F\B_T&T#%<8 56;G%FP.<5V^WH_)C>A03UWPD\=0$
M&0F&0ZXCM0;9<)!.>;)3=B<8#@XA<(+AX! ")Q@.#B%P@N'@$ (G& X.(7""
MX> 0 B<8#@XA<(+AX! ")Q@.#B%P@N'@$ (G& X.(7""X>#@X."0,IS1<'!P
M<'!(&<YH.#@X.#BD#&<T'!P<'!Q2AC,:#@X.#@XIPQD-!P<'!X>4X8R&@X.#
M@T/*<$;#P<'!P2%E.*/AX.#@X) RG-%P<'!P<$@9SF@X.#@X.*0,9S0<'!P<
M'%)&G1F-HL^>HIL__">Y+CD1W=;W'+KUX_]#KT]K32=C-__7SKUS5:>.TK,3
M_Y=N_>B?Y?;6IIRV4$B^_MSW*_0_[&_TRO=T: <'!X>S#W5F- 8N>9D-PKER
MOWDR*BB^E#H.NH8.5^W5H6L'N*?_@5&_H%9%N"->7:LM5VN'$*ZKQOW]$]=\
MHD,[.#@XG'VH.Z.Q]!7IL;<KNRHI%91<1IT&?8\.R77KM8>#E;OH@=&_I);%
MC=E8<-I,,!!A>6K3WQD-!P<'ASH>:9P3UX,/(QB-NP9]ET<:M6TT=M.#HV T
M+J9VI3S28 K+#\B--!P<'!QR?*11)T8C-M+ ])0R&F%Y<B,-!P<'!V<T:LEH
MF _W^$WT$3_X+IG_5)"-.-*%22_XJ^'[$W\$WL>0Z%T8$OD-B\NXA;VK8TCR
M)@_X/:,>!5'Y"W.K3T3ETT:U]I&H/*G$4U= /FQ> '8^@PCF/<S//Q;J<'H*
M1N/<4(4<I+-WI/&/W^ <'!P:-MQ((V8TO)5387E*QVCL./2E+.5]9,QOZ/%Q
MM]#C8W^O?GWT>WIL[,WTVK36M''_,@YE#$8ZAD/Y-7VYO4>VT7MSNM"CXW[+
M\?^.Z0^23C#M1\?=3$^._R_:7+Y<POF!N!+G 7Q9M_=SFK*VB/HL>(1>F-B,
M'AKU*[I[R ^H;=F5U*S?O]+MA>=3\\(+F!I17M%%3!=JNHA:\&_SHD9T>[^O
MBI_V [Y.]P^_@9Z;=!OU__PY6K5[+E6=.J93B\>1XP=HQ<Y/J7#1$_3TQ%NI
MZ[#KJ77)I=2LSWD27PN..Z_8I'612JL0:9U/'09\BWJ,_"G7>P%-6/,QU]D6
M'6L4TN%'<I0?VTDSUI?1!W.[T.-C?L]U]D/*-WGG^FC!^3=UU8++@/I3]7@!
MU^M7I<X*2B^GNP9^A[J-^ _FY^_HQ<DMZ./Y#]+HE>_3LNU3:7?%)CIRXJ!.
MT49RWH8!_-Y^: U]MFT\#5O^)KT[^QYZ?G)3ZCGF/^F^83^A.P9\0^J[&<NW
MY+4(/##\UE3,;0#E$5Z<3[?WY7(4?XWNX?(_P?*!_"_:.BZ!S*/WGUG^X\/Y
MX]A9L9&FKBNA-V?^A7JR/NC(NB>O\"+.HVY/-D\X_RB?XLGYPA/\W98[G)T&
M?X^ZC_@Y/3'^%GI]:@'U6_ X35[;3]KSGHK-5'FR0J?8L.$^A-?"A_!-K(R1
M_]9<CK9L<,+B$RIK0JTX[5>FM.1F;!IR.D+A%X8W9W2@EJPD0].RJ'7I9=2^
M[.NT9L]\'3(,*E[L97F=%6S'@==PW!=3L[[_RGENS/7!=25DC"WJ+KK^4B;$
MQTHQKY %E F&==;&P31@\8O4>?#W64C/5V5D?MC+H]MQ748MEXXD3BN_I+$8
MN7N'_)B-8!\Z4WU:RJWXD0XO%*ICRDVA@@W<@"4O<7NX1A1^/K<A4T\RLN5\
MR[/NG/CREX#:<2=&C8X13L75CLO3A@GRDP]CR74%Q88V]A8K1 _1Y1JQXFVZ
MBY4?>-N,%7MSKAO%[\LYW2NDSDR>,R?.L_5K1OB('[+8O-\%THF8O+8PQ@\_
MTN%+O-_=1S;3.[/OEO3 $W0XVO3G\J%LLH)2MRVNU]3;-->_J1?AARD7UUE)
M$VI3\C4I&SK.,$+Y_/?XU;UUCH#TVUI]P8TT:F%ZRF\T5*,*BQ-&"@T)O5ZE
M;&J&MS_M*(H]-"V+"K@LZ!U&&@VK_1ZJVLME^9Z4Q0BZE$<$'J0$1+E!</QI
MI4V(0RLF90BTX&E!]J=W-1/"Z'!II*^,.<*H,D$)%[ QA<+JM_ 12UFE)\S&
M^*_<-9ON&_H344K(5WNDP>52^<2S2EOR(F7!KY>_I 3_IFV)LN-Z8G?\MM=Q
MJ_)=);WBER8WEWPI1)>I[X*'972F^*SE@9\E_[$X5;YK0JK._6E(_4C>05>+
MH4+]]?JT$QVS>NF9JM?QJS\28]B21PPJ;55_[25]E;;D190^\H=G+\_)2!D=
M%5][S6L3GS$DIAY;L#$?\44OG3-&IH6J!^2DT8""NFO@=^E0Y1X=&C6:_5JM
M;Z,!]_RBQO3:=!B-FI?O+1@--D)A:=F4U&A8@.&&T8!"#8LK2$HY<EVRT-PA
M2IU[OR@_DQ(8K71*U3/J0$@,A!=/<D*<VI!H@8PI'G&[0BF#4LX#IP5%VI9_
MH324GV!\_ Z_' :]],Y#?T2[CFS4M9 ,'N]V5VRF[B-^2GE%YTL:RA @/_ZT
M5'Y!R(^JD_;P9_(61UQ'VI\Q+JI\*@[U3KD'"3W;EZ:TT#E,C#X+>E++0C5:
MC8H/!%XJ?JIV+/G7O%4&0;D9?@B/971H_*C\*D7+S_ 7FDX3V>S;IN0*6K1U
M@LYEE*R$ZXF5NV9)7O-%SI&W^'1,&Y)R<5Y0MVB3RJ"8,B*?6D?@O7:/E8')
M-A:&3T'".W1.1GSQELYAPT(=&XW4/H2#(:U*&E.7H=>S8ENH8\@^*JKVL]&X
MZ2PT&I>G;30PI146EY^N%G]YA8UXI/AOHCP?'WLSO3#I-GIG=F=Z>7(+F;]^
M<.0OJ<. ;XO@M.9A.OBMC CJ*;RNXH@%$E,*K4HND2F4.P9\G>/]!3TQ[A9Z
M<T8[^5:$[S<]1OR,%<YE,M5EIK1 [9%>7+QP5^_1)KH,^W?:=7B3KHDP^'FV
M8.M8;B-?X_0NU^F@34641Q0.$^<)!J8EMX.N0Z^CQ\;<3$^-^R,].=ZC)\;_
M@<O%]3;JYW3_B/^@3D-^*,HMEH9,BT2G51M&0XWR4$\7RV@ ^<$WK1[,\\?&
M_HZ>'/=?].S$6^G=.?=1KYD=N4SXOG8S=1G^[R)':",82:#-Q(Q,:#JJ7/ +
MI;]@RVB=T]0P=/D;/-+Z*H>W1ZJHLV!:JKPH-])"VVS+?.P^_$9ZC.L>WP"?
M8 (_GF)^X!??*C&]W6TX\X3E775(D&=#X65"&LYHI(!T1AHV8>X/#1,-$A_^
M%-UH/6=.78=?+\I3AHXA:=N4J=&0\ D:3]:-1C:FIRRD,]+ Q\['6)#2P>;R
M+^C1,;]EQ<GYAJ"EP LHR/;\"P5WX-@N'5-BG#ISDHH7/</IZ"-C(M*Q>XSX
M6(L/M-75B7BCWJW</9ON*/N&?*0.BQ?Q*>6H",:E'2NR":L_H=-G3DD<Z:#\
MZ Y14@4<AS$@,E(*H=HP&D@[O_@2FK2FCPZ9'LY4GZ$9Z\KH+P.^I3I7& 6&
M\03YT!V* M8%]PZYE@Y4[M:QA,'C%18Z8&HN+DXFCQ<H)WA^M1PGU'7X=;1X
M^R0=0WK  @?H*^B*L#1M D^<T4B"=#Z$YR+5RH=PIFP;#2C?L'1L2NU#N((R
M&M^5%3YA<=D$A?S(Z-_HD.GAHWD/L-%)GG<01@$/C/PY[:W8K$,;)%?N,]?U
MESGM-JPHPN(V4T5X;LU*\7[N:>X_NE/"^F E=?CX?NY%_UX^W@?C ZDI#586
M>.9T6_2[D-Z?TT6'!A"9H=2 %7I0W*H''=W&D"84U(N^;QK1$*,AWS0XK%9P
MP3A!6 @!PS=VU8<Z9+I093UV\C#U'/L;5MB-0],!R;<M&0E@!N(2&OG%.Q(V
M$;8>7,VC63;BD,% ?"I.%9_PA@D=GI$KWM:A#5+G!S!I;5\9.<.0)^()R(TT
M4D"F(XU<(?=-(_E( VD_PJ.&3+#EX"KI=8K A<1M$Q0'#IK$*AB%U!7NB=.5
M,K605]0H-&Z0\ O"S7G!R&';H34Z=#AF;1PBTRV8VPZ+3_5H06PPV-\+DYK&
M3G#VYSKU-A!F-$+39JJMD4;-C88J[YR-P]AH7,)IPC@$TU*\D&=^?WN_\^GU
MZ6TD7"+TY7+@8W/HB%+S0OVBLW,Q?<R=EIK"&(UD(PW4K3,:*2 =HQ%KL/I7
M&A,W4OE8EBE)7)KX;Z212-""Y(Q&[1J-PU7[9>X^E?PKH_%SVE.1Z'M#-%Z>
MDA<Y;6&3&HTTH>V'UNJ0X?A@3E>9%HQL3[HWB]XYE/S4=<4Z9.9H^$8#4&T>
M4Y0PT*COL+1LPHC@R?'_394GCTA8/U1\52<K99]47B2/43:E4^2[2NE5M$'V
M2M4,SFAD&>D8#5FYP$S-8X7:DAF/7AR&S#4A+"/$]$&K0K/F' TG6M""Y(Q&
M[1H-+$IXFI6!+$H(B=NFW# :'K]>G]Y>':\?UJL%0?FR@BHHODSVNVPLK[F"
M^L<P&@K88-EU^ WR/2 L+9M@-)Z:$&4T%'8?V4@/C/R%["^)*H,JG]HG]=C8
M6^A@9<VO87!&(\M(QVA@'K(S*ZK:V$%YXE2E[-+$1C',H\HR1Q%JK=PCA,\9
MC5HV&L?+61G\*:7\Y]I(XXWI;6-S\F'QP!W?MM"N[QSX'>[5+M$A,X<Q&O;\
M>5C:H%PW&GO8:'31N_K#TK+)&(VJ!$9CSY'-LI(N80=$UQE&B.BLH/W5%,YH
M9!GUOR,<2MFOF)$GS#&KZ2\C>.%Y0H_.?0@/C\]033Z$&Z.!.,+BM@G*H,?(
MFAF-VUF1AL5M$Q0R^)Z.T8@D;@>U833LD488H1.4FQ_"/8C1&'Z]C#3"TK()
MQY,\Q4H^5:,1%@?(E M& T8HFT;#?0C/$M(=:=3%CO#]Q[;+*IQ6HFB9R>;[
M1TB>W$C#C32BD-I(0W6&:M-HA*4-:A C#38:=3O24'*I1AI_=".--%#'1N/L
M..4V]XU&[6SN<T8CFL]04F@/=PZZQAF- .K<:*!LG'^43^+CD<N1*F<T4L59
M/=)PQXBXD48BRI;1$&(%948:F\J7ZI"9PQF-1!_"-\D,0O1( V53A%D&M+O#
M;J21,IS1B!D--*)L&8UE<G2U& VSW#<D3J0'9?/*U%:6T<C<>#BCD1JR;30^
MG-.-^8B=YM%\!N%X$7P+F+:^5(<$P._T>>Z,1K31P+MG)M[*Y6X4S1,]%6V^
M[T%F%3*7/V<TLHRSZ6CT?4>W4:<A.!D61T4@O&HH\81C4BZA^X;\F/8?W:I#
M9P[W(3PU9/M#^(QUI5I!A;<?* IUU$<35A;GLP)O3J?.G-"A@?0-A_L0'F4T
M5#U^,O]!Z1B$Q2'U);+.Q/()(]EWT6,2SD/ZQL-]",\RSJ:1QIGJD_0RCQY:
M<J\(>TY$883$B331>*%(/IK;78<.(MAXHQNS&VFDAFR/-&#P<9@@]@7(J:C!
MN*1M*7<L\882_V3>0SIT9L#>!B@\V9RF%534/I&S:Z2AY&/U[OET1YDZ7CV\
M'"R74E\X,!'[-1K+T>E^V+*6W(A,7]=?Z@2Z(K0=:$IN-)*G59^HXY'&N5)A
MR:BACS2 15O&4KZ<<82[(,+C5,I$-21,4W4>_ ,YQ3/3)M-KYIV45YC*2./R
MM$<:$.BPN&PZ6T<:P-0O2UGQ<"\3_&9EA/!&000)/,>)K1T'?H?F;AJN8T@-
MN-^D;/'SU&' -T5Q2T<'"C D'976V3G2 $H7/Z?N,]'U)%-2D+>0>%'.EH47
M4L\QOZ$O]RW2,:2&'8?7T7NS[V59Y[ADASE&&M%I@<*-!O(>+_W+=TRG]V;=
M0T^SL7QVXI_IF?%_HK_-Z$#S-J=WXF^VX$8:M? AW*#?PL?EK!R).R1."+LR
M5/PW-V@1?/Y;W5K7B#H.NH:ZX6CFL;]G0?FC*-6>HW_-;C?0O4-_Q'%<+?$W
M9\& LC53%6%IV>1&&MD<:7A"/FC)JY373T]3R7'EZG2#L+A%J? OCL_ [7KH
M%>,H]S>F%[#B?H1*/GN6>L_I1J].S1=W&!CPNC5W+M!FVI>BAPS%!$+;19R!
M-#2=;=\T#'!Z\-]X](WRJVEBD*ZKD+C-!W),,>$X==SI T6-$7SAPB>I^+-G
MZ)U9G>F5J2WIT7&_HPYEWZ06X G7 T9]4F=BH#@N?HZ:88"_Z)&&UYY&?M&+
M=>&E].F&@;26914G"H_C^L:UN)C>7+9]FJ13MN0E':)NX(Q&+1H-8.C2U^2(
M;=4KU *NCWH.2Z<NR!F-[$Y/V9BY88!,=6 T!^61:)HBFE@!08'IO]7W$,](
MF%]13J*L=-ORQ>'1V6HT#(H^>X*:]U6=-W515'C<B<G/$]2Y=/9,/3&I]@(_
M<-/DBT,1_"0S&M/6EW!\5]*NB@WR]RM3\JG/_)[R/&EM'QGI8958Q?']U&GP
MO]'PY7^3=W4!-SV5]>DI;XAI5D3A_/\GQ_Z!FO4]SQL-,(6E4Q?DIJ>R/SUE
M \??])K5B14#]T*Y+2<[%2 UTO=F<(<#]UC<._1:;D-7\XA#N8>'48KK[)J>
M"L?^8SNH)W=H<,>]NCJX9CQ!O2ICSITPEB<0[IGOT/_K[*:-A^4_2-'34PIX
MA]'G\5-'Y>\WI[=G7743/33Z5R*+6PZL%/=3IT]2]Q$_HY+/GY:_ZP(Y.]*X
M<^"W9/ZV-H$+?-!C%:/!C#2WMH7E27I6G*\)&5XZ YPX745C5O>F+D.N%84B
M)Z.BIRCW!2 =/",/_(Q\($_RJQHX?F-_PS]N3Y/>#QHB_.B\ZK"8^D #0SH0
M%K6RJ@EUYI[)J]-:R\?4>'@-%Y [P@<G&&D@32&UN_;AT?^I0Z8(G1Q.N<7M
M:%@\H)2LCE?2\-=!*U::/4;]C'97!*]C]><]"B],;E9K(PT%+Q_3UQ6S0KQ.
MIJ#D #W="S4*1_B$<G%ZX"TNE_)ZL(I0]^@IXY*GHL^>HF,G#E,Y*\$V[ YE
M)2,-CE?BM/)O"$>$8\66A^AZZK/@81EIJ+S%QV4(\H#O<*-7O*=#I@LO#SCB
MONNPZZ2M2IE#TC-D1AJ5I](S&@8P-@.7OLSZY=ORO4.-;E#/D"5.0]<]ZE+Q
M".^,NVJ#D%D8;H2'+(U;U5OBGK:N1.H$<J>FJ?@WD'\0C)88C>76'>%2']["
M>QR=__+D/.K)G;!#Q_?Q2.)-&J/K>N[F$?3BI.:T?O]B>D-NJ/P]G3AU3-[5
M!>K,:(Q:^9Z:HP^Y0<\FW*;WT,B;:-Z6D3HD$-W(:P*P:,+JC^0;P?TCKF.Z
M4;XAA.9KQ W49=A/:.;Z,AVZYL#)KLMV3*.RSU^@YR8UE6LC.[."1D\%'U6Q
M1/FV/N=0TS[_(K^W]3F/_OS).3)BD?7@K#3P0?3N(3^2JU4Q-?3*U )6+$_R
MB.AC6KYS.FT]N$IZ\>G!JV\,?Q]A0X!K.OUU@GI"O:DZ@V)\F'M"_NLXD_'-
M+RAS-XV0TTGO'W:#CO]&%;\A3@>7(B'=,2O>US?>(?09_1L%_4[_K-FW4*[P
M[!I7)C_=+^6[@78=5E,$Z<.?I[U'M\G\]-NS.G-GY9<R!0N%CY% TT^^PGP^
MCWE[#O?@&].=@[[#_/PU%2UZDM;L7:!C,*AFI7*<!G-'#/("0GZ[!_*OZ$8Y
M_!-S\29L,%\V!BQ^D=O3]R4<VF-WJ?OX.*'D_SZO!RMAU1/.#"H?N%5Q-.L'
MG'1[/Y-)0_':G_;=0W](;TQOQ^EF1TEN.[B&QK$.>'E**^H^\J>LH["_ZE(V
M\HVT[)TK\I;/'488B&<G_ \-906^(Z0C45%U@.OY;NHR]">2?T7^_!L"3R:L
M_KL.:6#XXO$'TU,8971C'K\PZ79Z=6HK.?:]._/FY2DM:,M!->*H2]29T:@9
MHAMY_2##_"2\-C278#?>S/-<+<H\$3CN6)UDEHX7"D_)XJA96IE"I9:--!%'
MYO$DWT!:DSQF$I;#2+":I)LID&:VT\U6?":>5/*8[3(D1P,Q&@X.#@X.N0!G
M-!P<'!P<4H8S&@X.#@X.*<,9#0<'!P>'E.&,AH.#@X-#RG!&P\'!P<$A93BC
MX>#@X."0,IS1<'!P<'!(&<YH.#@X.#BD#&<T'!P<'!Q2AC,:#@X.#@XI@NC_
5 ]D=B,UO?SK@     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>imagea.jpg
<DESCRIPTION>HUM LOGO
<TEXT>
begin 644 imagea.jpg
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MN&J?/%?SOWN'_%B>NXWX*1T\MD>>IZXK85_5PME\G=$VI4UBX?'[TI06\ES
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M,23'X!B20W#,R"$X9N00'#-R"(X9.03'C!Q")#-6[9DG2_M >X]NTZ[QP')
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M$ (G& X.(7""X> 0 B<8#@XA<(+AX! ")Q@.#B'(2#"&+O\KC5[YOH_&KOQ
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5 ]D=B,UO?SK@     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139873844107312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 12,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Humana Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-5975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-0647538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 West Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">580-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HUM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>hum-20220912_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hum-20220912.xsd" xlink:type="simple"/>
    <context id="id33311a3840449e2a4a07beb00d38882_D20211201-20211201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-01</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV80L2ZyYWc6YWJkYTcyMzhlOGFhNGNhMmEzYWM0ZjdmMTdmMWFmYjgvdGFibGU6ZWE0NTg0YjQxMTA1NGJmOGI0NDE5YjVjZmVkNzlmNjAvdGFibGVyYW5nZTplYTQ1ODRiNDExMDU0YmY4YjQ0MTliNWNmZWQ3OWY2MF8yLTEtMS0xLTEzODU_553b26ba-8dca-422e-8576-78b3ab6a2841">0000049071</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV80L2ZyYWc6YWJkYTcyMzhlOGFhNGNhMmEzYWM0ZjdmMTdmMWFmYjgvdGFibGU6ZWE0NTg0YjQxMTA1NGJmOGI0NDE5YjVjZmVkNzlmNjAvdGFibGVyYW5nZTplYTQ1ODRiNDExMDU0YmY4YjQ0MTliNWNmZWQ3OWY2MF8zLTEtMS0xLTEzODU_44077ab1-c2af-45f3-b148-6cfc5b4c045c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc1_544a42e1-eda2-47be-95bf-fbc8409d561c">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8yNDM_d8fd9718-a683-419e-a11b-3a815c843b9b">2022-09-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjgw_b8191588-2209-47d9-a94b-b4d348d263b9">Humana Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6OTgxOTA4MmUxMmI3NDMzZjg2NWQyMDAwMmZiN2M0Y2IvdGFibGVyYW5nZTo5ODE5MDgyZTEyYjc0MzNmODY1ZDIwMDAyZmI3YzRjYl8wLTAtMS0xLTEzODU_bd9aa2db-a0b4-4fa8-b816-f02f906f72f9">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6OTgxOTA4MmUxMmI3NDMzZjg2NWQyMDAwMmZiN2M0Y2IvdGFibGVyYW5nZTo5ODE5MDgyZTEyYjc0MzNmODY1ZDIwMDAyZmI3YzRjYl8wLTEtMS0xLTEzODU_fd7ad2d9-0512-4268-81ce-f8abff4c7034">001-5975</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6OTgxOTA4MmUxMmI3NDMzZjg2NWQyMDAwMmZiN2M0Y2IvdGFibGVyYW5nZTo5ODE5MDgyZTEyYjc0MzNmODY1ZDIwMDAyZmI3YzRjYl8wLTItMS0xLTEzODU_fff3bc9b-5145-4f9c-aaa5-d8776cd8d03f">61-0647538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc3_ebd7e028-9c6b-4901-a297-bf3b428e8148">500 West Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc4_40807ae2-02a0-45de-9148-e8350fa794eb">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc5_5320bfd8-c5bc-4dcf-9ab2-620b1b9e4579">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjcy_e2ddf632-a860-445f-8eb6-c213c5fd8b48">40202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjcz_343bf26e-04c4-40bd-89ed-5487c80cf5c8">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjgx_c3dad3b4-9f4c-4494-beb3-5d3cfbf879a2">580-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6MGU4MmFmZTVhZTQxNDg4YjgwMjM0NTNhNjIyOWNkNmQvdGFibGVyYW5nZTowZTgyYWZlNWFlNDE0ODhiODAyMzQ1M2E2MjI5Y2Q2ZF8wLTAtMS0xLTEzODU_bb05ca88-5b46-4a45-a479-a8723e17b9a3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6NTU3NmMxNGFlMWRlNGZhY2JkNzZhNzNjOWU3YTI4MWYvdGFibGVyYW5nZTo1NTc2YzE0YWUxZGU0ZmFjYmQ3NmE3M2M5ZTdhMjgxZl8wLTAtMS0xLTEzODU_06de4d67-89a9-42c9-952e-6e67bef01a89">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6M2U4ZTA5ZWQwOTk1NGUxZWEyMjY2NDc4YTAwYzc4ZjEvdGFibGVyYW5nZTozZThlMDllZDA5OTU0ZTFlYTIyNjY0NzhhMDBjNzhmMV8wLTAtMS0xLTEzODU_bf24071d-066b-462b-a84c-512d6a5c4daa">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6YmM1MDJiNDE1ZWE3NGM4M2EwM2Y2Mjc1ZDg2MGM3ZDQvdGFibGVyYW5nZTpiYzUwMmI0MTVlYTc0YzgzYTAzZjYyNzVkODYwYzdkNF8wLTAtMS0xLTEzODU_39c98030-d84d-4b5c-82c0-18057f91041c">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6ZDVhZmQ0YzVjZDJhNGE2ODhkNGM3ZGMwMzRkOTk4NmEvdGFibGVyYW5nZTpkNWFmZDRjNWNkMmE0YTY4OGQ0YzdkYzAzNGQ5OTg2YV8xLTAtMS0xLTEzODU_9051b8d1-bd17-4bc2-b50f-853475a2571c">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6ZDVhZmQ0YzVjZDJhNGE2ODhkNGM3ZGMwMzRkOTk4NmEvdGFibGVyYW5nZTpkNWFmZDRjNWNkMmE0YTY4OGQ0YzdkYzAzNGQ5OTg2YV8xLTEtMS0xLTEzODU_159cd904-2bbb-417b-8b0c-22983e241f2e">HUM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGFibGU6ZDVhZmQ0YzVjZDJhNGE2ODhkNGM3ZGMwMzRkOTk4NmEvdGFibGVyYW5nZTpkNWFmZDRjNWNkMmE0YTY4OGQ0YzdkYzAzNGQ5OTg2YV8xLTItMS0xLTEzODU_1afc2c1e-4fd2-49b3-ba97-8c85fe560c7f">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="id33311a3840449e2a4a07beb00d38882_D20211201-20211201"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0ZTNhYTFjOTE4NzQ0OTg4Y2JmN2M5NjZiNDc4ODAxL3NlYzpkNGUzYWExYzkxODc0NDk4OGNiZjdjOTY2YjQ3ODgwMV8xL2ZyYWc6NDRhYTc2MmJmNjdhNDA0MGE1MWI0NWM1NmY5N2EyMDgvdGV4dHJlZ2lvbjo0NGFhNzYyYmY2N2E0MDQwYTUxYjQ1YzU2Zjk3YTIwOF8xMjc0_98ea2052-714b-465a-a288-9df0a49841d9">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( -TZ+U4'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ W3HO5=LDIB7N    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ W3HO59E<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #=.B]5
MI4S.&BP$  !6$   &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ W3HO59^@&_"Q @  X@P   T
M     ( !;PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #=.B]5EXJ[',
M   3 @  "P              @ %+#P  7W)E;',O+G)E;'-02P$"% ,4
M" #=.B]5JL0B%C,!   B @  #P              @ $T$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ W3HO520>FZ*M    ^ $  !H
M ( !E!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
MW3HO5660>9(9 0  SP,  !,              ( !>1(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  PQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hum-20220912.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0540-DocumentPeriodEndDate-Value] In submission type 8-K, DocumentPeriodEndDate value "2022-09-12", is not equivalent to header element periodOfReport value "09-15-2022" in the Required Context. hum-20220912.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="hum-20220912.htm">hum-20220912.htm</File>
    <File>exhibit991directorelection.htm</File>
    <File>exhibit992investorday.htm</File>
    <File>hum-20220912.xsd</File>
    <File>hum-20220912_lab.xml</File>
    <File>hum-20220912_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hum-20220912.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "hum-20220912.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hum-20220912_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hum-20220912_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hum-20220912.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hum",
   "nsuri": "http://www.humana.com/20220912",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20220912.htm",
      "contextRef": "id33311a3840449e2a4a07beb00d38882_D20211201-20211201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.humana.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20220912.htm",
      "contextRef": "id33311a3840449e2a4a07beb00d38882_D20211201-20211201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000049071-22-000060-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000049071-22-000060-xbrl.zip
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MKIPJSJ?R>TJ$EH;VX&%3P=E][AK-\Z!=I'?!=K5<65] A-IWEN<QPA#[9-<
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MHU?S'?].7W "DJ8[8.3;N+42PI>N+Z:A'0</-61)WO8O.:+6?%\K9T1:*"4
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MXB4>O.@#<'ZVPW6:.HD_9#\_T(T"M_?\>^CH>8^&"=_K_GNR5;/3G T.GIU
MH9^PI*<Y/88A%;&O(FA1[F=AZ9!%']Y7R.8B[0-S[MO\/=;\?>;F\WEN/N\O
M5IL6J[BWS.V;D+[(2<;^W $&SWLAG_A-/E_EU&V(YFJ$Y0FE\CDL:4E47J<-
MM+T[QS&0(GQF@:@SEHI%\OR/.LE(?M/.'HOMN.Y\W6R^C'S&S7WA[S_./PGN
M_+;L!]JM?T= <R,WZY7GJ4GB"TE4>_H+XW?+\+HX.[6.6I?GC8N[4DK729\'
M)K#"1^;I98L3_WDE_S=/3_[O"&R81;K8#KLI\A#W^7I>LSL*IH)#1BG/M/$9
M#O.E;FC&SE,\X$&<KX;;M$\"KU@JYQ _?X&%%4<1E.'5+3.M=MVGP<;@.VS#
M=ZX]>2ZOJI45M7K/.(*D&(\11ZBJNQUUL55#5E^R2ME^B=F?E^:1=22<6<?E
M;<[S!I)+ZG=2H+=F,?_ JZ_/Z-@^I']T:J_3Z-C>G4I:$3[&_0A])J- :)>%
M$QJ CKE/J&4'SKCO7MDG/'YIMV%[NB&[[Z@\0:1_^T+&!8U\<#^^^@X5F&_B
M,_6_+QSW?>J!/EWLTIEG9@N_DW#(DKG9\F<0K(SC#SLLCSB:S\%C>Y\7%T7=
M'+9[7C^I/9L%5F<+J+4MR_ROVK^HV+$[A3_@B0>'_P-02P,$%     @ W3HO
M51DJ:!%H @  90<  !    !H=6TM,C R,C Y,3(N>'-DS57?:]LP$'[/7Z'Y
M>;)L)VECTZ2PEL(@VZ!K:=^&+)\345OR)+G)_OM)BDWJM%D7V,,@$.GN^^Z7
M[LX7E]NZ0L^@-)=B'L1A%" 03!9<K.;!_=T-G@67B]'HX@/&CY]NE^A:LK8&
M8="5 FJ@0!MNUNBA /V$2B5K]"#5$W^F&"\\Z4HVOQ1?K0U*HB0YU*IL.DD8
MY%.&QRP?X\ETEN"<3E+,9N-S1BF4T[/RXRJ+BB))R_@<4YI0/"G9%.=G.> 4
MDC-*)VQ6S@IO=*LSS=904V03$SK;ZGFP-J;)"-EL-N%F'$JU(DD4Q>3QR_*[
MAP8=MN+B:8#>YJKJ\6/BU#G5T,/7;3U VSL5-&2R)B[7*(V3 %%C%,]; S=2
MU==0TK8R\Z 5/UM:\9)#8>M=@:OH /!";:A:@?E*:] -9?"NR\4((5<&7C=2
M&23>)'9UB-,T)5N76(!V95M*1HWOA:-U\'CLCCA.\#@.M[H(R%^Y'1KB0ALJ
M&)SBV]YPS_L7,>P?];08>M[I,7AC&EBXDL^D .Y>+G[;O3X&=P?L#D.?5 AI
M/-]).EG3<%'*G<"*7.!9'_TME/V<O&K^-UK$_V54,26K=_J)-$HVH P'_7)P
MO(&U@M*RVQKW3?NCHGEH ^D1K^P/7\"IB:5 M=PGTG/-K\9RM:U_!;O2_,=Y
M-PI.S=M2M%T7_IE/3-_Q[ZP>\6(>7$F[]@/D9/>WGX^M%>]R!^UM]=8**+G@
MOMLBNT_M#^']]P$CS[H@A]@#*ZV&XIM8^/-A:AVY@_R!R&C%VNITWCZLH[1.
MV)>N&RPRG*S=_<7T><%NI!>CWU!+ P04    " #=.B]5?6+T^W\*  !)7@
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M&MDS8@UX=_R)UX*-DNVN"9M];.3M%^O_SM-,P3FC*E 1"T$L<0!(("'@ @I
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MR47,D1%<_;04&<EQ;\QB=%PXL04IO  _2!?YU'6Q#6XG(9+#$# $S>T7%FS
M%HP;Z2/6VTYS1Z2CEEB.B9++)&6*"A^LV8) GH$>) XU=7&,Y71*PCC"GQ_2
M67U9+8P*.>1.$@%&8S&%+AC% ==#F>N<&>'IN.KY!>!!HM#?B"@VY'-*DNCS
MH@_I--5?B\K#@N8QQ$ 9D8HK],/BQBBI)+G,+6.Y,3S;QG[R//H@<9AO1!QC
MF)V20D[KIK7EG\5YGS9'M)9G'HC(L/B65@KB+-,$1*9SRCC68MNH6Y_#'M;,
MHM^(/#:G]97%T2UZAPEL;[>D&>?."X(V!E2VPDW0TDB"44)$9B6Z,ZX)>P]M
MF  FW,[<F+I7#GGWG*,\7=757?E$G0X@8R">*TFDSG M<R:0:&CDX(0'.VZ7
M>(PX+/03[F*.HO"5P_\Y%6T+U5&]7E]4MR52LU!1R$P:K(ER%@G6S)(XSCDN
M62H&*R,ZP$9IX%G884*8< ]S/)FOK(9/=5GXHBVJY:^8X*3"E@O0.O+<!R)L
M *R'!%9&F,X0YEET5@0D9US/\BGF,!U,N$<YDL97%L%I@D[!@(EM_WRN>[2;
M/D2T8Y%I%3)+-:%:=GDN.F"]Q$K(62[QG&5NW%.NE[&'B6+"?<HMT3HM<1PW
MS06D^[XH&\'E7A%J!-9#3&CBLI!W>:_V%(-M85Q/ZM\L&":4"3<NMTKQ:V\H
MX"]P4[QFW)T5;=D50UJK+,L(&-FUUT3WC!^W124SSXV"Z.6XHN(QXC Y3+A5
M.8K"5P[_6;+=BVJ?KM>N+A<N"&$T,$*%U42"RHF-6!59K2CZ(RR3XY:&!W##
M C_A=N3FY$WDIG]WY5>V6D+_*#^S5GE&@? L1Q:$B<2(+"<4\R'<^@ 4/'Z%
M;;,;_S[J, U,N.LXFLI)=!O?K2$M4<J_I/JR7>'F=FZKZX4QN'0Y[TB@@%5R
M+B)Q(=<D!"G!!NG&*N(?P(>].#7Y?N-X8B>ACR.D+-GR&%.<J__!]<)[KQQH
MM#T&CP+/@#@J-?'&^#R(Z$085V8\"SM,$Q-N08XG\Y75<(CY;NARWO>E72ZZ
MQVO4*$E$;K$JRJ(A3GB&'UA+YYQET8]+%1_ #8O^A+N0FY.WM:B_F3\A[P0/
M'.S<GN@^NC?A#W;^#U!+ 0(4 Q0    ( -TZ+U6-W@LR< D  "LM   >
M          "  0    !E>&AI8FET.3DQ9&ER96-T;W)E;&5C=&EO;BYH=&U0
M2P$"% ,4    " #=.B]54E?CD=<F  !&_@  &0              @ &L"0
M97AH:6)I=#DY,FEN=F5S=&]R9&%Y+FAT;5!+ 0(4 Q0    ( -TZ+U7)WSA:
MLA@  -^A   0              "  ;HP  !H=6TM,C R,C Y,3(N:'1M4$L!
M A0#%     @ W3HO51DJ:!%H @  90<  !               ( !FDD  &AU
M;2TR,#(R,#DQ,BYX<V102P$"% ,4    " #=.B]5?6+T^W\*  !)7@  %
M            @ $P3   :'5M+3(P,C(P.3$R7VQA8BYX;6Q02P$"% ,4
M" #=.B]5U\;S-:L&  #7,   %               @ 'A5@  :'5M+3(P,C(P
A.3$R7W!R92YX;6Q02P4&      8 !@"3 0  OET

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
